The use of Ursolit for gallstone prophylaxis following bariatric surgery: a randomized-controlled trial
Authors:
- Nasser SakranNasser Sakran
- Ron DarRDRon Dar
- Ahmad AssaliaAAAhmad Assalia
- Ziv NeemanZNZiv Neeman
- Moaad FarrajMFMoaad Farraj
- Shiri Sherf-DaganSSShiri Sherf-Dagan
- Ian M. GralnekIGIan M. Gralnek
- Rawi HazzanRHRawi Hazzan
- Shams Eldin MokarySMShams Eldin Mokary
- Hadar Nevo-AboodyHNHadar Nevo-Aboody
- Tamar DolaTDTamar Dola
- Uri KaplanUKUri Kaplan
- 14 July 2020
- journal article
- research article
- Published by Springer Nature in Updates in Surgery
- Vol. 72 (4) , 1125-1133
Abstract
Background Although bariatric surgery (BS) predisposes patients to development of gallstone formation, a preventive strategy is still in debate. Aim To compare the incidence of gallstone formation between patients treated with ursodeoxycholic acid (UDCA) vs. placebo for a duration of 6 months following BS. Methods This multicenter randomized, double-blind controlled trial entails treatment with UDCA vs. an identical-looking placebo. The primary outcome was gallstone formation, as measured by abdominal ultrasound. Results The data of 209 subjects were enrolled in the study, and 92 subjects completed the study and were analyzed (n = 46 for each study group). The high dropout rate was mainly due to difficulties in adding more medications and swallowing the pill. Among the subjects who completed the study, 77.2% were women, and their mean age and pre-surgery BMI were 42.2 ± 10.2 years and 44.4 ± 6.1 kg/m2, respectively. Gallstone formation was recorded in 45.7% (n = 21) vs. 23.9% (n = 11) of subjects among placebo vs. UDCA groups, respectively, p = 0.029. Subgroup-analysis, according to surgery type, found that the results were significant only for SG subjects (p = 0.041), although the same trend was observed for OAGB/RYGB. Excess Weight Loss percent (%EWL) at 6 months post-surgery was 66.0 ± 17.1% vs. 71.8 ± 19.5% for the placebo and UDCA groups, respectively; p = 0.136. A trend towards a reduction in prescribed comorbidity medications was noted within-groups during the follow-up period, as compared to baseline, with no between-group differences (p ≥ 0.246). Moreover, no between-group differences were found for blood test results (p ≥ 0.063 for all). Conclusion Administration of UDCA significantly decreased gallstone formation at 6 months at following BS. ClinicalTrials.gov number NCT02319629.Keywords
This publication has 29 references indexed in Scilit:
- Comparison of the incidence of cholelithiasis after sleeve gastrectomy and Roux-en-Y gastric bypass in obese patients: a prospective studySurgery for Obesity and Related Diseases, 2015
- Comparison of cholecystectomy cases after Roux-en-Y gastric bypass, sleeve gastrectomy, and gastric bandingSurgery for Obesity and Related Diseases, 2014
- Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery*Obesity, 2013
- Cost-effectiveness analysis of cholecystectomy during Roux-en-Y gastric bypass for morbid obesitySurgery, 2012
- Incidence of postoperative gallstone disease after antiobesity surgery: population-based study from SwedenSurgery for Obesity and Related Diseases, 2010
- Ursodeoxycholic Acid in the Prevention of Gallstone Formation after Bariatric Surgery: A Meta-analysisObesity Surgery, 2008
- Gallstone Formation Prophylaxis After Gastric Restrictive Procedures for Weight LossAnnals of Surgery, 2003
- Impact of Rapid Weight Reduction on Risk of Cholelithiasis after Bariatric SurgeryObesity Surgery, 2003
- Prevention of Gallstone Formation in Morbidly Obese Patients Undergoing Rapid Weight Loss: Results of a Randomized Controlled Pilot StudyJournal of Surgical Research, 2002
- A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight lossThe American Journal of Surgery, 1995